Supplemental material
Open access
726
Views
0
CrossRef citations to date
0
Altmetric
Research Article
Risk of neutropenia in psoriasis patients prescribed anti-IL-23 antibody in comparison with anti-IL-17 antibody or adalimumab based on real-world data from the MID-NET® in Japan
Yusuke Okadaa Office of Pharmacovigilance II, Pharmaceuticals and Medical Devices Agency, Tokyo, Japan;b Office of Pharmacovigilance I, Pharmaceuticals and Medical Devices Agency, Tokyo, JapanView further author information
, Kazuhiro Kajiyamaa Office of Pharmacovigilance II, Pharmaceuticals and Medical Devices Agency, Tokyo, Japan;b Office of Pharmacovigilance I, Pharmaceuticals and Medical Devices Agency, Tokyo, Japan;c Office of Regulatory Science Research, Center for Regulatory Science, Pharmaceuticals and Medical Devices Agency, Tokyo, JapanView further author information
, Chieko Ishigurod Office of Medical Informatics and Epidemiology, Pharmaceuticals and Medical Devices Agency, Tokyo, JapanView further author information
, Takahiro Nonakad Office of Medical Informatics and Epidemiology, Pharmaceuticals and Medical Devices Agency, Tokyo, JapanView further author information
, Tomomi Komakia Office of Pharmacovigilance II, Pharmaceuticals and Medical Devices Agency, Tokyo, JapanView further author information
, Wataru Kugaa Office of Pharmacovigilance II, Pharmaceuticals and Medical Devices Agency, Tokyo, JapanView further author information
, Noriyuki Komiyamaa Office of Pharmacovigilance II, Pharmaceuticals and Medical Devices Agency, Tokyo, JapanView further author information
, Toyotaka Iguchia Office of Pharmacovigilance II, Pharmaceuticals and Medical Devices Agency, Tokyo, JapanView further author information
, Naoya Horiuchib Office of Pharmacovigilance I, Pharmaceuticals and Medical Devices Agency, Tokyo, JapanView further author information
& Yoshiaki Uyamad Office of Medical Informatics and Epidemiology, Pharmaceuticals and Medical Devices Agency, Tokyo, Japan;e Center for Regulatory Science, Pharmaceuticals and Medical Devices Agency, Tokyo, JapanCorrespondence[email protected]
https://orcid.org/0000-0002-0430-9887View further author information
Article: 2373826
|
Received 01 Apr 2024, Accepted 06 Jun 2024, Published online: 04 Jul 2024
Related research
People also read lists articles that other readers of this article have read.
Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.
Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.